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Introduction {#sec001}
============

*Leptospira* spp. are the causative agents of leptospirosis, a neglected global zoonosis. Leptospirosis is currently re-emerging due to global warming and causes about 60,000 deaths per year worldwide \[[@ppat.1008639.ref001]\]. Infection by pathogenic species such as *L*. *interrogans* in humans may often cause asymptomatic or "flu-like" infections, but can also cause severe disease with a fatality rate of up to 10%. Notably, it may also be an overlooked cause of chronic kidney disease \[[@ppat.1008639.ref002]\]. All other vertebrates can be infected, with symptoms varying from one species to another. For instance, infection may cause morbidity and abortion in cattle or uveitis in horses \[[@ppat.1008639.ref003]\]. Rodents such as mice and rats play an important role in the endozoonotic cycle of the disease because they are resistant to acute infection and can, like wild animals or cattle, become lifelong reservoirs of these bacteria \[[@ppat.1008639.ref003]\]. Upon infection with *Leptospira*, the proximal renal tubules may become chronically infected leading to excretion of bacteria in urine and transmission of the disease \[[@ppat.1008639.ref004],[@ppat.1008639.ref005]\]. Unlike most other spirochetes, like *Borrelia burgdorferi* and *Treponema pallidum*, respective agents of Lyme disease and syphilis, *Leptospira* spp. possess a lipopolysaccharide (LPS) as one of their outer membrane components \[[@ppat.1008639.ref006]\]. This LPS is an essential molecule for the bacterial outer membrane integrity and is known to contribute to leptospiral virulence \[[@ppat.1008639.ref007]\]. The LPS is composed of a hexa-acylated lipid A, allowing anchoring in the outer membrane, and a succession of sugar units distributed between inner core, outer core and O antigen. It is the molecular basis for classification of *Leptospira* into more than 300 different serovars \[[@ppat.1008639.ref008]\]. Furthermore, leptospiral LPS has been described as atypical in terms of structure. First, the lipid A possesses the following unconventional structures: (i) non-saturated fatty acid chains; (ii) a 2,3-diamino-2,3-dideoxy-D-glucose (DAG) disaccharide backbone carrying 4 primary amide-linked fatty acids; (iii) a methylated 1-phosphate group and (iv) no 4'-phosphate group \[[@ppat.1008639.ref009]\]. The lack of reactive phosphate groups is most probably responsible for the lack of human TLR4 recognition \[[@ppat.1008639.ref010]\]. Additionally, silver stained electrophoretic profiles of LPS from pathogenic leptospiral strains were shown to be different from that of *E*. *coli* LPS \[[@ppat.1008639.ref011]\] and the carbohydrates composing the O antigen were described to be more irregular and complex than the classical repeated units pattern \[[@ppat.1008639.ref012]\]. The leptospiral O antigen LPS biosynthesis *rfb* locus was found to be between 4 to 120 kb \[[@ppat.1008639.ref013]--[@ppat.1008639.ref015]\] long, depending on the species and strains. In *L*. *interrogans* and *L*. *borgpetersenii* it was described to include at least 30 open reading frames \[[@ppat.1008639.ref016],[@ppat.1008639.ref017]\]. Among the various genes of the locus, glycosyl transferases and integral membrane proteins involved in full-length LPS transport were identified as well as enzymes for rhamnose sugar biosynthesis \[[@ppat.1008639.ref017]\]. However, most of these open reading frames encode proteins of unknown function and the overall structure of the O antigen section of the leptospiral LPS remains unknown. Interestingly, LPS of saprophytic species of *Leptospira* was found to be short, although not completely rough \[[@ppat.1008639.ref011]\].

Molecular Associated Microbial Patterns (MAMPs) are conserved molecules among microbes that are recognized by the host innate immune system *via* Pattern Recognition Receptors (PRRs). PRRs can be soluble or expressed in cells, either membrane-bound or cytosolic. Activation of these cellular PRRs leads to the production of pro-inflammatory cytokines and chemokines that are the signals that orchestrate the immune response \[[@ppat.1008639.ref018]\]. Among these PRRs, the plasma membrane Toll-Like-Receptor 4 (TLR4) and Toll-Like-Receptor 2 (TLR2) sense bacterial LPS and bacterial lipoproteins, respectively. Subsequent activation of signaling pathways *via* the adaptors MyD88/TIRAP leads to the early nuclear translocation of the transcription factor NF-κB, a central regulator of inflammatory and antimicrobial responses. In addition, upon LPS stimulation, TLR4 is also endocytosed. Signaling from endosomal TLR4 relies on the TRIF/TRAM adaptors and induces late NF-κB translocation as well as IRF3 activation, leading to the production of IFN-β, and interferon stimulating genes \[[@ppat.1008639.ref019]\]. Many cofactors play essential roles in the activation of TLR4 by bacterial LPS, including the LPS-binding protein (LBP) and the co-receptor cluster of differentiation 14 (CD14) that is either soluble or attached by a glycosylphosphatidylinositol (GPI) anchor on the surface of mononuclear phagocytes \[[@ppat.1008639.ref020]\]. Many studies have highlighted the important roles of CD14 for the efficient signaling of the LPS, and it was shown that it is important for TLR4 internalization and TRIF signaling \[[@ppat.1008639.ref019],[@ppat.1008639.ref021],[@ppat.1008639.ref022]\].

The LPS of *L*. *interrogans* is unconventional in its recognition by the PRRs of the innate immune system. First, it is differentially recognized by the human and mouse TLR4. Leptospiral LPS activates the mouse, but not the human TLR4 \[[@ppat.1008639.ref023]\]. In addition, in mouse cells leptospiral LPS has very low endotoxic activity compared to other bacterial LPS such as from *Escherichia coli* \[[@ppat.1008639.ref023],[@ppat.1008639.ref024]\]. Another signaling particularity of the leptospiral LPS is that it activates TLR2, both in human and mouse cells \[[@ppat.1008639.ref024],[@ppat.1008639.ref025]\]. This immunological property is independent of the Lipid A moiety \[[@ppat.1008639.ref023]\] and could be attributed to co-purifying lipoproteins. It has been described that the co-receptor CD14 is needed for this TLR2 activation \[[@ppat.1008639.ref024]\]. Of note, these co-purifying lipoproteins resist the classical hot water/phenol extraction and mild proteinase K treatment \[[@ppat.1008639.ref024]\], suggesting strong interaction with the LPS. There are more than 170 open reading frames encoding putative lipoproteins in the genome of *L*. *interrogans* \[[@ppat.1008639.ref026]\]; most of them are of unknown function. Among these, LipL32 is the most abundant lipoprotein. It was shown not to be essential for virulence \[[@ppat.1008639.ref027]\] and to be a TLR2-TLR1 agonist \[[@ppat.1008639.ref023],[@ppat.1008639.ref024],[@ppat.1008639.ref028]\]. On the other hand, Loa22, another abundant lipoprotein was shown to be essential for leptospiral virulence \[[@ppat.1008639.ref029]\]. Even though most of the functions of these lipoproteins remain unknown, previous publications showed that some leptospiral lipoproteins play a role in the innate immune escape. Indeed, LipL21 binds tightly to the leptospiral peptidoglycan and hence prevents its recognition by the PRRs NOD1 and NOD2 \[[@ppat.1008639.ref030]\]. Additionally, LipL21 and other lipoproteins have also been described as inhibitors of neutrophil myeloperoxidase \[[@ppat.1008639.ref031]\].

To our knowledge, the mechanism underlying the low endotoxicity of the leptospiral LPS seen in mouse cells \[[@ppat.1008639.ref023],[@ppat.1008639.ref024],[@ppat.1008639.ref032]\] has never been investigated. Moreover, the role of the co-purifying lipoproteins that often contaminate leptospiral LPS preparations and confer their TLR2 activity remains to be studied. Hence, in this study we aimed to characterize the atypical signaling of the leptospiral LPS in murine cells and to elucidate the role of these co-purifying lipoproteins.

Results {#sec002}
=======

Leptospiral LPS does not trigger mouse-TLR4 internalization {#sec003}
-----------------------------------------------------------

Upon stimulation with bacterial LPS, it was described that surface TLR4 is internalized \[[@ppat.1008639.ref022]\] within the first hour. Therefore, we first assessed whether that was the case upon stimulation with leptospiral LPS. Surprisingly, immunofluorescence analysis of RAW264.7 cells stimulated for 1 h with LPS of the pathogenic *L*. *interrogans* strain Verdun revealed that mouse-TLR4 (mTLR4) remained localized on the plasma membrane, in contrast to stimulation with *E*. *coli* LPS, after which mTLR4 localization was intracellular ([Fig 1A](#ppat.1008639.g001){ref-type="fig"}). The mTLR4 specificity of the anti-TLR4 antibody was confirmed using TLR4 KO bone marrow derived macrophages (BMDMs) ([S1A Fig](#ppat.1008639.s002){ref-type="supplementary-material"}). mTLR4 fluorescence profiles were further quantified on cross-sections ([S1B Fig](#ppat.1008639.s002){ref-type="supplementary-material"}) performed on at least 40 cells and were averaged to estimate the localization of the mTLR4 receptor upon stimulation. These quantifications confirmed that the plasma membrane localization of mTLR4, characterized by a two-peak distribution of the fluorescence profile, was modified only upon stimulation with *E*. *coli* LPS, but not *L*. *interrogans* LPS ([Fig 1B](#ppat.1008639.g001){ref-type="fig"}). This phenotype was confirmed with flow cytometry analyses and surface mTLR4 staining on stimulated RAW264.7 cells. We observed that the mean fluorescence intensity (MFI), corresponding to surface mTLR4, decreased only upon stimulation with LPS of *E*. *coli* ([Fig 1C](#ppat.1008639.g001){ref-type="fig"}, left panel and [S1D Fig](#ppat.1008639.s002){ref-type="supplementary-material"}). Given that leptospiral serovars have different LPS, we further showed that mTLR4 internalization was not induced by LPS of any of the 3 main serovars of *L*. *interrogans* (Icterohaemorrhagiae strain Verdun; Copenhageni strain Fiocruz L1-130; Manilae strain L495) ([Fig 1C](#ppat.1008639.g001){ref-type="fig"}, right panel). This was consistent with the similar LPS profiles observed between the different serovars after silver staining ([S1C Fig](#ppat.1008639.s002){ref-type="supplementary-material"}). To exclude the possibility that the LPS of *L*. *interrogans* could induce a delayed internalization of mTLR4, we performed cytometry analyses at different time points and showed that there was no delayed internalization of the leptospiral LPS, even after 24 h of stimulation ([S1E Fig](#ppat.1008639.s002){ref-type="supplementary-material"}). Furthermore, to assess a potential effect of the dose of LPS on mTLR4 internalization, we showed that the leptospiral LPS did not trigger mTLR4 internalization at either 100 ng/mL or 1 μg/mL ([S1F Fig](#ppat.1008639.s002){ref-type="supplementary-material"}).

![Leptospiral LPS does not trigger TLR4 internalization.\
**A)** Representative images of confocal IF analyses of RAW264.7 macrophage-like cells upon 1h stimulation with 100 ng/mL of LPS of *Escherichia coli* or LPS of *Leptospira interrogans* and staining for mouse-TLR4 (mTLR4), glycoproteins (Weat Germ Agglutinin, WGA) and nuclei (DAPI). **B)** Average mTLR4 fluorescence profiles quantified on cross-section of the cells (see [S1B Fig](#ppat.1008639.s002){ref-type="supplementary-material"} for more details) either non-stimulated (grey), stimulated with LPS of *E*. *coli* (blue) or LPS of *L*. *interrogans* (green). Data are represented as mean of \> 40 cells and shades correspond to +/- SD. **C)** Flow cytometry analysis of surface mTLR4 (or isotype) on RAW264.7 cells upon 1h stimulation with 1μg/mL of LPS of *E*. *coli* (blue) or *L*. *interrogans* (green) (left panel) and corresponding mean fluorescence intensities (MFI) (right panel) with various serovars of *L*. *interrogans* LPS (serovar Icterohaemorrhagiae strain Verdun, serovar Copenhageni strain Fiocruz L1-130, serovar Manilae strain L495) (see [S1D Fig](#ppat.1008639.s002){ref-type="supplementary-material"} for complete gatings). Each dot of MFI corresponds to the analysis of one well (10 000--30 000 events). All experiments shown are representative of at least 3 independent experiments and statistical analyses were performed using the non-parametric Mann-Whitney test.](ppat.1008639.g001){#ppat.1008639.g001}

Leptospiral LPS avoids TRIF responses but activates MyD88 at high concentrations {#sec004}
--------------------------------------------------------------------------------

Since leptospiral LPS was unable to trigger internalization of mTLR4, we then investigated whether either MyD88- (plasma membrane adaptor) or TRIF- (endosome adaptor) dependent responses were induced 24 h post stimulation. We first showed, using WT and MyD88 KO BMDMs that the production of the KC chemokine was fully dependent on the MyD88 adaptor, with no difference in the production induced by LPS of *L*. *interrogans* or LPS of *E*. *coli* ([Fig 2A](#ppat.1008639.g002){ref-type="fig"}, left panel). Consistent with previous studies \[[@ppat.1008639.ref024]\], we confirmed that the KC production upon leptospiral LPS stimulation was dependent on both TLR4 and TLR2 ([S2A Fig](#ppat.1008639.s003){ref-type="supplementary-material"}), and we confirmed using TLR2/TLR4 DKO BMDMs that only TLR2 and TLR4 contribute to LPS signaling in the case of both *L*. *interrogans* and *E*. *coli* LPS ([S2B Fig](#ppat.1008639.s003){ref-type="supplementary-material"}), consistent with our previous work \[[@ppat.1008639.ref023]\]. On the other hand, we showed that the production of RANTES was largely dependent on the TRIF adaptor pathway ([S2C Fig](#ppat.1008639.s003){ref-type="supplementary-material"}) and that the LPS of *L*. *interrogans* induced around 3 times less RANTES than the LPS of *E*. *coli* ([Fig 2A](#ppat.1008639.g002){ref-type="fig"}). Furthermore, the production of nitric oxide (NO), a potent antimicrobial compound \[[@ppat.1008639.ref033]\], which we also showed to be fully dependent on the TRIF adaptor ([S2C Fig](#ppat.1008639.s003){ref-type="supplementary-material"}), was almost completely blunted upon stimulation with the leptospiral LPS, while it was elicited in a dose dependent manner by the LPS of *E*. *coli* ([Fig 2A](#ppat.1008639.g002){ref-type="fig"}). In addition, both RANTES and iNOS were analyzed at the transcriptional level in RAW264.7 cells. RT-qPCR revealed that the leptospiral LPS induced much lower TRIF-dependent responses than *E*. *coli* LPS ([Fig 2B](#ppat.1008639.g002){ref-type="fig"}). Similarly, we analyzed the levels of IFN-β mRNA and our results also showed that the LPS of *L*. *interrogans* induced lower production of IFN-β mRNA, compared to the LPS of *E*. *coli* ([Fig 2C](#ppat.1008639.g002){ref-type="fig"}). We further controlled that the IFN-β mRNA levels were representative of the cytokine production and that the induction of IFN-β was dependent on the adaptor TRIF ([S2D Fig](#ppat.1008639.s003){ref-type="supplementary-material"}). These results indicated that leptospiral LPS avoids TRIF-dependent, but not MyD88-dependent, responses. Surprisingly, we showed that at lower concentration, leptospiral LPS avoided not only the TRIF-dependent NO production, but also the production of MyD88-dependent KC ([S2E Fig](#ppat.1008639.s003){ref-type="supplementary-material"}). These results suggest that at high concentrations, the leptospiral LPS escapes the mTLR4 internalization and specific TRIF-dependent responses, whereas at low concentrations, the leptospiral LPS escapes both pathways.

![Leptospiral LPS avoids TRIF-dependent responses but activates MyD88.\
**A)** Production of KC, RANTES and NO by WT and MyD88 KO BMDMs after 24h stimulation with 500 ng/mL, 1 μg/mL and 2 μg/mL of LPS of *L*. *interrogans* (*L*.*i*, green) or LPS of *E*. *coli* (*E*.*c*, blue). **B)** mRNA levels of RANTES, iNOS and **C)** IFN-β in RAW264.7 cells after stimulation with 1 μ/mL of LPS of *L*. *interrogans* (*L*.*i*, green) or LPS of *E*. *coli* (*E*.*c*, blue). Data are represented as mean (+/- SD) of *n =* 3/4 technical replicates and are representative of at least 3 independent experiments. Statistical analyses were performed using the non-parametric Mann-Whitney test.](ppat.1008639.g002){#ppat.1008639.g002}

Shorter leptospiral LPS induces more TLR4-TRIF responses {#sec005}
--------------------------------------------------------

Because we showed that the leptospiral LPS could induce signaling *via* the TLR4-MyD88 pathway, we hypothesized that the TRIF-escape phenotype we observed was not due to a poor interaction of the lipid A with mTLR4. Instead, we hypothesized that the O antigen of the LPS could be involved in the TRIF escape. Therefore, we investigated whether different leptospiral LPS could induce the internalization of mTLR4 and trigger responses *via* the TRIF adaptor. We first studied the LPS from *L*.*interrogans* Manilae strain M895, an attenuated strain that produces a shorter LPS. This LPS was compared to the LPS of the WT strain Manilae L495 after quantification of lipid A acyl chains and estimation of their respective molar concentration. We confirmed the truncation of this LPS, which showed a downward shift of the upper band visible on silver staining ([Fig 3A](#ppat.1008639.g003){ref-type="fig"}). Immunofluorescence analyses of RAW264.7 cells stimulated for 1 h by this shorter M895 LPS revealed that the localization of mTLR4 was slightly modified upon stimulation, as quantified by the reduction in the two peaks corresponding to the membrane associated mTLR4 and the increase on the internalized signal ([Fig 3B](#ppat.1008639.g003){ref-type="fig"}), although some mTLR4 remained visible on the membrane of the cells ([Fig 3C](#ppat.1008639.g003){ref-type="fig"}). Furthermore, we showed that this shorter LPS induced more RANTES and more NO production (TRIF-dependent responses) than the same molar concentration of the full-length leptospiral LPS ([Fig 3D](#ppat.1008639.g003){ref-type="fig"}). Analyses of the mRNA levels of RANTES, iNOS and IFN-β confirmed that the short LPS of the M895 strain triggers more TRIF-dependent responses that the full-length L495 leptospiral LPS ([Fig 3E and 3F](#ppat.1008639.g003){ref-type="fig"}).

![Shorter leptospiral LPS induces more TLR4-TRIF responses.\
**A)** Silver staining analyses of two LPS: the full-length LPS of the WT L495 strain and the shorter LPS of the mutant M895 strain after SDS-PAGE with the equivalent of 0.1 pmol of LPS/well. Positions of standard molecular mass markers are shown on the left. **B)** Average mouse-TLR4 (mTLR4) fluorescence profiles quantified on cross-section of RAW264.7 cells either stimulated by the equivalent 10 nM (≈ 100 ng/mL) of the full-length LPS L495 (dark green) or the shorter LPS M895 (light green). The two LPS used were purified from *L*. *interrogans*, serovar Manilae WT strain L495 or mutant strain M895. Data are represented as mean of \> 40 cells and shades correspond to +/- SD. **C)** Representative images of confocal IF analyses of RAW264.7 cells upon 1h stimulation with the equivalent of 10 nM of LPS L495, LPS M895 or LPS of *E*. *coli*, and staining for mTLR4, glycoproteins (Weat Germ Agglutinin, WGA) and nuclei (DAPI). **D)** Production of RANTES and NO by RAW264.7 cells after 24h stimulation with 50-200 nM (≈ 0.5-2 μg/mL) of full-length LPS of *L*. *interrogans* L495 (dark green), shorter LPS of *L*. *interrogans* M895 (light green) or LPS of *E*. *coli* (blue). **E)** mRNA levels of RANTES, iNOS and **F)** IFN-β in RAW264.7 cells after 24h stimulation with 100 nM of full-length LPS of L495 (dark green), shorter LPS of M895 (light green) or LPS of *E*. *coli* (blue). Data are represented as mean (+/- SD) of *n* = 3/4 technical replicates and are representative of at least 3 experiments. Statistical analyses were performed using the non-parametric Mann-Whitney test.](ppat.1008639.g003){#ppat.1008639.g003}

In addition, we also purified and characterized the LPS of the saprophytic *L*. *biflexa* (*L*.*b*) serovar Patoc strain Patoc and showed that it was much shorter than the LPS of the pathogenic species ([S3A Fig](#ppat.1008639.s004){ref-type="supplementary-material"}). Because the structure of the Patoc Lipid A is unknown, we could not estimate its exact molar concentration. Nevertheless, based on same LPS amount by weight, HEK reporter system analyses showed that both Patoc and Verdun LPS had similar mouse-TLR4 activity in comparison with internal control (LPS of *E*. *coli*) ([S3B Fig](#ppat.1008639.s004){ref-type="supplementary-material"}), whereas the LPS of Patoc had no TLR2 activity, in contrast to Verdun LPS ([S3B Fig](#ppat.1008639.s004){ref-type="supplementary-material"}). Noteworthy, no differential activities between the human and mouse-TLR2 receptors were observed, hence allowing us to work indifferently with either one of these receptors to monitor the TLR2 activity of our LPS preparations. We further confirmed by analyses of TLR4 KO and TLR2 KO BMDMs that the signaling of Patoc LPS was TLR2-independent ([S3C Fig](#ppat.1008639.s004){ref-type="supplementary-material"}). Consistent with the results of the M895 shorter LPS, we showed that the short Patoc LPS induced in macrophages a higher production of RANTES and NO than the Verdun LPS ([S3D Fig](#ppat.1008639.s004){ref-type="supplementary-material"}). Altogether these data strongly suggest that the full-length intact LPS is important to avoid mTLR4 internalization and subsequent TRIF-dependent responses.

Soluble CD14 participates in the enhanced signaling of the shorter LPS {#sec006}
----------------------------------------------------------------------

After investigating the bacterial components that could be involved, we decided to assess whether host factors could also be implicated in the mechanism. We first investigated the role of serum in the signaling. Both full-length and shorter leptospiral LPS benefited from serum addition for RANTES production ([S4 Fig](#ppat.1008639.s005){ref-type="supplementary-material"}). Next, we investigated whether serum components could contribute to the differential signaling observed between the full-length and the shorter LPS. CD14 appeared as a good candidate given its role in TLR4 endocytosis \[[@ppat.1008639.ref022]\] and in the signaling of leptospiral LPS *via* TLR2 \[[@ppat.1008639.ref024]\]. Stimulation of RAW264.7 macrophages in serum-free medium, supplemented with increasing doses of recombinant soluble CD14 (sCD14) revealed that both RANTES and NO productions, as well as IFN-β mRNA production in response to the shorter M895 LPS were dependent on the presence of sCD14 ([Fig 4A and 4B](#ppat.1008639.g004){ref-type="fig"}). Surprisingly, the presence of sCD14, even at 500 ng/mL, did not trigger the production of NO by the full-length L495 leptospiral LPS ([Fig 4A](#ppat.1008639.g004){ref-type="fig"}). sCD14 mediates TLR4-signaling by binding and delivering LPS to the TLR4-MD2 complex \[[@ppat.1008639.ref034]\]. Thus, to further characterize the role of sCD14 in the M895 LPS signaling, binding assays were performed on high resolution 20% acrylamide gels and visualized by silver staining and Western Blots (WB). On silver staining, the band corresponding to sCD14 disappeared in the presence of both LPS (that remains in the upper part of the gel), suggesting a binding between the molecules. However, the disappearance of the sCD14 band was much more prominent with 0.01 pmol of the shorter M895 LPS than with the same dose of the L495 LPS ([Fig 4C](#ppat.1008639.g004){ref-type="fig"}, left panel), suggesting a better binding of sCD14 to the short M895 LPS. These results were confirmed by WB targeting sCD14 *via* the polyHistidine tag ([Fig 4C](#ppat.1008639.g004){ref-type="fig"}, right panel), on which the shifted sCD14 upper band was detectable and much more visible in the presence of the short M895 LPS. Overall, these results suggest that the full-length LPS has a lower affinity for sCD14 than the shorter LPS, which could explain why it escapes mTLR4 internalization and TRIF-responses.

![Soluble CD14 participates in the enhanced signaling of the shorter leptospiral LPS.\
**A)** Production of RANTES and NO by RAW264.7 cells after 24h stimulation in serum free conditions, with 0-500 ng/mL of recombinant bovine sCD14 and after stimulation with 100 nM (≈ 1 μg/mL) of full-length LPS of *L*. *interrogans* L495 (dark green), shorter LPS of *L*. *interrogans* M895 (light green), or 1 μg/mL of LPS *E*. *coli* (blue). **B)** mRNA levels of IFN-β in RAW264.7 cells after 24h stimulation with 0-500 ng/mL of recombinant bovine sCD14 and after stimulation with 100 nM (≈ 1 μg/mL) of full-length LPS of *L*. *interrogans* L495 (dark green), shorter LPS of *L*. *interrogans* M895 (light green), or 1 μg/mL of LPS *E*. *coli* (blue). **C)** Binding assay of recombinant bovine sCD14 to the full-length L495 and shorter M895 leptospiral LPS. Native 20% gel electrophoresis of the LPS (0.01--0.04 pmol/well) + sCD14 complexes revealed by silver staining (left panel, 100 ng/well of sCD14) or Western Blot targeting sCD14-His (right panel, 200 ng/well of sCD14) show the band of sCD14 that disappears or gets shifted in presence of LPS. Data are represented as mean (+/- SD) of *n* = 3/4 technical replicates and are representative of at least 3 independent experiments. Statistical analyses were performed using the non-parametric Mann-Whitney test. RT-qPCR performed in technical duplicates were not used in the statistical analyses.](ppat.1008639.g004){#ppat.1008639.g004}

Co-purifying lipoproteins contribute to the escape of internalization {#sec007}
---------------------------------------------------------------------

Because of the striking lack of TLR2 activity of the saprophytic Patoc LPS ([S3B Fig](#ppat.1008639.s004){ref-type="supplementary-material"} and [S3C Fig](#ppat.1008639.s004){ref-type="supplementary-material"}), we also investigated whether lipoproteins co-purifiying with the leptospiral LPS could participate in the escape of TLR4-TRIF pathway. Indeed, one of the particularities of *L*. *interrogans* LPS extracted in the phenolic phase using the Westphal method is that it always co-purifies with lipoproteins \[[@ppat.1008639.ref035]\]. These contaminants are responsible for the TLR2 activity of the leptospiral LPS, but the role of these co-purifying lipoproteins has never been further investigated. We therefore repurified LPS preparations of the Verdun strain. Quality controls of this repurification on HEK reporter system ([Fig 5A](#ppat.1008639.g005){ref-type="fig"}) indicated that the TLR2 activity was almost totally removed in the repurified LPS (compared to the original), without altering mTLR4 activity. Stimulation of TLR2 KO BMDMs confirmed that, compared to the original LPS, there was no contribution of TLR2 to the signaling of the repurified LPS ([Fig 5B](#ppat.1008639.g005){ref-type="fig"}). Furthermore, silver staining analysis showed that the overall structure of the LPS was not altered by the treatment ([Fig 5C](#ppat.1008639.g005){ref-type="fig"}). Among other lipoproteins, we identified the LipL21 ([Fig 5C](#ppat.1008639.g005){ref-type="fig"}) as co-purifying with the LPS; and it was significantly decreased upon repurification. Stimulation of RAW264.7 cells by the original and repurified LPS showed that the localization of mTLR4 was slightly modified when stimulated with the repurified LPS compared with the original LPS ([Fig 5D and 5E](#ppat.1008639.g005){ref-type="fig"}). In BMDMs we observed consistently increased production of TRIF-dependent RANTES and NO, but not of MyD88-dependent KC upon stimulation with the repurified LPS ([Fig 5F](#ppat.1008639.g005){ref-type="fig"}). These findings were confirmed by mRNA analyses of RANTES and iNOS ([Fig 5G](#ppat.1008639.g005){ref-type="fig"}). Finally, IFN-β mRNA was also increased after stimulation by the repurified LPS ([Fig 5H](#ppat.1008639.g005){ref-type="fig"}). These results suggest that the presence of co-puryfing lipoproteins would have an inhibitory role and would impair the leptospiral signaling through TRIF.

![Copurifying lipoproteins contribute to the escape of TLR4 internalization.\
**A)** Human embryonic kidney cells **(**HEK293T) reporter system for mouse-TLR4 (left axis) and human-TLR2 (right axis) activities of 1 μg/mL of the original LPS of *L*. *interrogans* strain Verdun before repurification (LPS O., dark green) or repurified leptospiral LPS (LPS R., light green), with the corresponding controls: 100 ng/mL of LPS of *E*. *coli* for mTLR4 activity and 100 ng/mL of Pam3Cys for hTLR2 activity. **B)** Production of KC by WT and TLR2 KO BMDMs after 24h stimulation with 1 μg/mL of LPS O. (dark green), LPS R. (light green) or 100 ng/mL of LPS of *E*. *coli* (blue). **C)** Silver staining analyses of original or repurified LPS of *L*. *interrogans* after SDS-PAGE with the equivalent of 1 μg of LPS/well (left panel) and Western Blot showing LipL21 contamination in the two LPS preparations (right panel). Positions of standard molecular mass markers are shown on the right. **D)** Representative images of confocal IF analyses of RAW264.7 macrophage-like cells upon 1h stimulation with 100 ng/mL of LPS of *Leptospira interrogans* original, repurified, or LPS of *E*. *coli* and staining for mouse-TLR4 (mTLR4), glycoproteins (Weat Germ Agglutinin, WGA) and nuclei (DAPI). **E)** Average mTLR4 fluorescence profiles quantified on cross-section of the cells either stimulated by the original (dark green) or the repurified leptospiral LPS (light green). Data are represented as mean of \> 30 cells and shades correspond to +/- SD. **F)** Production of KC, RANTES and NO by BMDMs after 24h stimulation with 1 μg/mL of LPS O. (dark green), LPS R. (light green) or LPS of *E*. *coli* (blue). **G)** mRNA levels of RANTES, iNOS and **H)** IFN-β in BMDMs cells after 24h stimulation with 1μ/mL of original (dark green) or repurified (light green) LPS of *L*. *interrogans* or LPS of *E*. *coli* (blue). Data are represented as mean (+/- SD) of *n* = 3/4 technical replicates and are representative of at least 3 independent experiments. Statistical analyses were performed using the non-parametric Mann-Whitney test. RT-qPCR performed in technical duplicates were not used for statistical analyses.](ppat.1008639.g005){#ppat.1008639.g005}

To confirm the implication of the co-purifying lipoproteins in escape from the mTLR4-TRIF pathway, we also treated the leptospiral LPS preparations with either proteinase K or lipase. Results with the HEK reporter system showed that these treatments did not affect mTLR4 activity ([S5A Fig](#ppat.1008639.s006){ref-type="supplementary-material"} and [S5B Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). Interestingly, lipase digestion only (not proteinase K) resulted in the expected reduction in the TLR2 activity of the LPS ([S5A Fig](#ppat.1008639.s006){ref-type="supplementary-material"} and [S5B Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). Consistent with the repurification data, leptospiral LPS preparations digested with proteinase K (and not lipase) induced increased RANTES production in macrophages ([S5C Fig](#ppat.1008639.s006){ref-type="supplementary-material"} and [S5D Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). We checked that the proteinase K treatment did not alter the structure of the leptospiral LPS ([S5E Fig](#ppat.1008639.s006){ref-type="supplementary-material"}) and that it efficiently degraded flagellin ([S5F Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). All together, these data suggest that the lipoproteins contribute to the TLR4-TRIF escape *via* the protein moiety and not *via* the lipid anchors. LipL32 was also found to copurify with the leptospiral LPS, and to be decreased upon repurification ([S5G Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). Since it is the major lipoprotein present in the outer membrane of leptospires and is the only one to have been shown to be a TLR2 agonist \[[@ppat.1008639.ref024],[@ppat.1008639.ref028]\], we also purified and stimulated macrophages with the LPS of *L*. *interrogans* Manilae mutant strain M933 ΔLipL32. Although the molar concentration of the LPS preparations was not measured, using similar amounts (as estimated by weight), the mutant LPS did not have a lower TLR2 activity than the WT LPS ([S5H Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). Additionally, there was no increased production of RANTES ([S5I Fig](#ppat.1008639.s006){ref-type="supplementary-material"}). These results suggest that the phenotype was not due to a single specific lipoprotein. This led us hypothesize that lipoproteins are redundant regarding escape of the internalization of TLR4.

Whole bacteria induce responses consistent with LPS signaling properties {#sec008}
------------------------------------------------------------------------

Our data showed that leptospiral LPS escapes mTLR4 internalization and that full-length LPS and co-purifying lipoproteins are important features for avoiding TRIF responses. Therefore, we investigated whether the LPS responses could mimic an infection with whole bacteria. No internalization of mTLR4 was visible 1-hour post infection of macrophages with live WT *L*. *interrogans* Manilae L495, whereas infection with live Manilae M895 induced internalization of the mTLR4 ([Fig 6A](#ppat.1008639.g006){ref-type="fig"} and [Fig 6B](#ppat.1008639.g006){ref-type="fig"}). Furthermore, we tested the TRIF-dependent RANTES and NO productions 24 h post infection and we observed that, although there was no significant difference in RANTES production, the WT L495 strain induced less NO than the mutant M895 strain ([Fig 6C](#ppat.1008639.g006){ref-type="fig"}). Of note, experiments with live bacteria were performed using MOI comprised between 10 and 50, which could relate to 1 μg/mL of LPS according to our estimations, although such comparison must be interpreted with caution. These results show that the signaling of the leptospiral LPS is, to some extent, representative of the responses induced by whole bacteria, and that live WT leptospires also escape the mTLR4 internalization and part of the TRIF-dependent antimicrobial responses.

![Whole bacteria induce responses similar to corresponding LPS.\
**A)** Representative images of confocal IF analyses of RAW264.7 macrophage-like cells upon 1h stimulation with either MOI 50 of whole live bacteria *L*. *interrogans* L495 or mutant M895 and staining for mouse-TLR4 (mTLR4), glycoproteins (Weat Germ Agglutinin, WGA) and nuclei (DAPI). **B)** Average mTLR4 fluorescence profiles quantified on cross-section of the cells (*n* \> 30) either non-stimulated (grey) or stimulated by whole *L*. *interrogans* L495 or mutant M895 (green). **C)** Production of RANTES and NO by RAW264.7 cells stimulated 24h by MOI 12.5--50 of whole live bacteria *L*. *interrogans* WT L495 (dark green) or mutant M895 (light green). Data are represented as mean (+/- SD) of *n* = 3/4 technical replicates and are representative of at least 3 independent experiments. Statistical analyses were performed using the non-parametric Mann-Whitney test.](ppat.1008639.g006){#ppat.1008639.g006}

Discussion {#sec009}
==========

Overall, our data show that the leptospiral LPS escapes mTLR4 internalization and consequently avoids the activation of TRIF-dependent responses such as NO, IFNβ and RANTES in murine macrophages. Using shorter and repurified LPS, we demonstrated the effect to be dependent on the presence of a full-length O antigen and co-purifying lipoproteins. Furthermore, we showed that it is the protein moiety of these lipoproteins that is important for the escape of mTLR4 internalization. In addition, we showed that the full-length O antigen of the leptospiral LPS impairs the binding to CD14, known to be instrumental for TLR4 endocytosis. Finally, we showed that the phenotype described with leptospiral LPS was representative of an infection by whole live bacteria. These data therefore suggest that the leptospiral LPS, that was already known to fully escape hTLR4 recognition in humans that are sensitive, also escapes part of the TLR4 responses in mice. We therefore hypothesize that this partial escape of recognition by the innate immune system could play a key role in the stealthiness of the bacteria and chronic kidney colonization in the resistant mouse model ([Fig 7](#ppat.1008639.g007){ref-type="fig"}).

![Summary of the TLR4 recognition of the leptospiral LPS in human and mouse.\
Schematic representation of the difference between: the lack of TLR4 recognition in humans that leads to full immune escape of the leptospires from TLR4 and may cause susceptibility to acute leptospirosis; and the partial lack of TLR4 recognition in mice that (although protects from acute leptospirosis) could account for partial immune escape of the leptospires and contribute to the chronicity of the infection in mice.](ppat.1008639.g007){#ppat.1008639.g007}

Interestingly, CD14 was described as essential for TLR4 endocytosis and TRIF pathway activation, at both high and low LPS doses and in both macrophages and endothelial cells \[[@ppat.1008639.ref036],[@ppat.1008639.ref037]\]. Our results also suggest that sCD14 enhances TRIF responses to the shorter LPS of the leptospiral mutant M895. This could be due to a stronger binding of the mutant LPS to sCD14 compared to the full-length LPS. Conversely, we hypothesize that the poor binding of the leptospiral LPS to sCD14 could limit TLR4-TRIF signaling. Furthermore, we showed that at lower concentrations, leptospiral LPS escapes both the MyD88 and the TRIF pathways, as illustrated by the lack of KC and NO production. Again, the poor binding of the LPS to CD14 is consistent with these results, given that CD14 is essential for both the MyD88 and the TRIF pathways upon stimulation by low concentrations of LPS \[[@ppat.1008639.ref020],[@ppat.1008639.ref036]--[@ppat.1008639.ref041]\]. This is reminiscent of another study that described poor binding of CD14 to atypical LPS of *Helicobacter pylori* and *Porphyromonas gingivalis* \[[@ppat.1008639.ref042]\]. Given that full-length and shorter LPS of *L*. *interrogans* Manilae strains L495 and M895 have the same lipid A, it is reasonable to hypothesize that CD14 poorly binds to the leptospiral LPS because of steric hindrance due to the length of the O antigen, which could be a cause of its altered signaling. This would be consistent with previous studies showing that smooth LPS (S-LPS) depends on CD14 to activate cells \[[@ppat.1008639.ref040],[@ppat.1008639.ref043]\]. On the other hand, it is established that rough LPS (R-LPS) depends on CD14 mainly for TLR4 endocytosis \[[@ppat.1008639.ref021],[@ppat.1008639.ref022]\], although some studies reported both *in vitro* and *in vivo* that R-LPS could benefit from the presence of CD14 \[[@ppat.1008639.ref021],[@ppat.1008639.ref044]\]. Accordingly, several other studies have described R-LPS as a more potent agonist of the innate immune system than S-LPS \[[@ppat.1008639.ref040],[@ppat.1008639.ref044]--[@ppat.1008639.ref047]\]. Overall, such findings are consistent with our results showing that the shorter LPS naturally signals more *via* TRIF than the full-length LPS, and that sCD14 contributes to this enhanced signaling. Complementation experiments restoring the complete structure of the shorter LPS mutant would have been valuable to confirm a direct link between the LPS structure and signaling properties. However, the available genetics tools for *L*. *interrogans* are limited, hence making complementation a real challenge. Previous attempts at complementing the M895 mutant using a modified transposon have failed as none of the selected transformant strains exhibited a full-length LPS, almost certainly due to the very large transcriptional units that make up the LPS biosynthetis locus \[[@ppat.1008639.ref007]\].

In addition, we showed that the copurifying and omnipresent lipoproteins were also responsible, at least in part, for the lack of TLR4 intracellular signaling. We hypothesize that these lipoproteins also affect CD14 binding and that they could potentially play a role in CD14 sequestration. Indeed, CD14 was shown to be important for the signaling of triacylated lipoproteins *via* TLR2-TLR1 \[[@ppat.1008639.ref048]\] especially in the case of spirochetal lipoproteins \[[@ppat.1008639.ref024],[@ppat.1008639.ref049]--[@ppat.1008639.ref052]\]. Furthermore, we hypothesize that this phenomenon might not be specific to *Leptospira* and could be conserved among bacteria. Indeed, there are other LPS that possess the ability to activate TLR2, such as *H*. *pylori* or *Porphyromonas* spp. \[[@ppat.1008639.ref053]--[@ppat.1008639.ref055]\]. Many studies identified lipoproteins as the TLR2-activating contaminants in LPS preparations \[[@ppat.1008639.ref055],[@ppat.1008639.ref056]\]. In the case of *L*. *interrogans*, LipL32, the most abundant lipoprotein \[[@ppat.1008639.ref027]\], was shown to be a TLR2 agonist \[[@ppat.1008639.ref024],[@ppat.1008639.ref028],[@ppat.1008639.ref057]\]. Furthermore, many groups worked on purifying these contaminated LPS preparations and reported the loss of TLR2 activity upon extensive repurification \[[@ppat.1008639.ref055],[@ppat.1008639.ref058]\]. Surprisingly, the loss of TLR2 activity upon repurification did not necessarily blunt the stimulatory properties of the LPS. Although not discussed by the authors, several studies showed similar or enhanced TNF-α production upon stimulation by repurified LPS \[[@ppat.1008639.ref055],[@ppat.1008639.ref058]\]. Such findings are consistent with our results that showed enhanced TRIF signaling upon repurification and removal of the co-purifying lipoproteins. It is of note that the efficiency of these repurification processes differs according to LPS. LPS naturally harboring TLR2 activity (*H*. *pylori*, *P*. *gingivalis*, *L*. *interrogans*) seem to be more difficult to repurify than classical LPS from *Salmonella* \[[@ppat.1008639.ref024],[@ppat.1008639.ref055],[@ppat.1008639.ref058]\]. Purification of the leptospiral LPS from the phenol (and not aqueous) phase of the Westphal method \[[@ppat.1008639.ref035]\], most probably due to the hydrophobicity of its O chains, could contribute to the co-purification with other hydrophobic molecules such as lipoproteins, hence making this LPS harder to purify with the classically described methods. Further biochemical studies would be required to understand whether those lipoproteins may directly impair the LPS binding to CD14 and how they may promote the TLR2 signaling while dampening TLR4-TRIF responses. One interesting result of our study was obtained with the LPS from the mutant M933 ΔLipL32 that showed no enhanced TRIF activation compared with the WT LPS, suggesting that the lipoproteins could be redundant. In the case of *L*. *interrogans*, over 170 putative lipoproteins have been described, but their function remains mostly undetermined. We showed that LipL21 contributes to the escape of the immune system *via* very tight binding to peptidoglycan (PG) that required 4 hours boiling in SDS to be detached from the PG \[[@ppat.1008639.ref030]\], hence preventing its recognition by the PRRs of the NOD family NOD1 and NOD2 \[[@ppat.1008639.ref030]\]. Therefore, *L*. *interrogans* in which the abundance and variety of the lipoproteins is unusual, allowed us to highlight once more a potential new role for bacterial lipoproteins in innate immune escape. In particular for this phenotype, the redundancy of lipoproteins highlights this mechanism as a potential key strategy employed by leptospires to evade the immune response.

Although we mainly focused our study on the potential role of the lipoproteins and the O antigen that could impair the binding to CD14, we cannot exclude the possibility that other host factors might be involved. Among them is the lipopolysaccharide-binding protein (LBP). The LBP functions as a catalyst allowing for the binding of monomeric LPS to CD14 that is then transferred to TLR4 *via* interaction with the myeloid differentiation factor 2 (MD2) \[[@ppat.1008639.ref034]\]. Although the LBP greatly facilitates the transfer of the LPS to the soluble CD14, it is not essential to the signaling \[[@ppat.1008639.ref059]\]. Just like CD14, LBP plays an important role in the CD14-dependent endocytosis of TLR4 \[[@ppat.1008639.ref019]\] and plays a crucial role in the signaling of low doses of LPS *via* MyD88 \[[@ppat.1008639.ref060]\]. Interestingly, in the case of *L*. *interrogans*, LBP was shown to be the only serum factor upregulated in the blood of patients upon infection \[[@ppat.1008639.ref061]\]. Therefore, we cannot exclude that LBP contributes to the effect. Finally, we cannot exclude the possibility that the escape of TLR4 internalization upon stimulation by leptospiral LPS could be due to a CD14/LBP-independent mechanism. For instance, stimulation by a mycobacterial phenolic glycolipid (PGL) induces similar dampening of the TRIF-associated responses in macrophages \[[@ppat.1008639.ref062]\]. This effect was associated with TRIF protein level (and not mRNA) decrease after at least 6h of stimulation by PGL \[[@ppat.1008639.ref062]\]. However, we do not favor this hypothesis, given that we consider the lack of TRIF-response to be the direct consequence of the lack of TLR4 internalization that we showed to be already apparent at 1 h post stimulation.

Interestingly, the M895 mutant of Manilae with shorter LPS is attenuated in hamsters \[[@ppat.1008639.ref007]\] and has lost its ability to colonize kidneys in BALB/c mice \[[@ppat.1008639.ref063]\]. Other examples of such a correlation between the reduced size of the LPS and an altered infection course of the corresponding bacteria have been published. For example, the deep-rough LPS mutant of *B*. *bronchiseptica* is defective for lung colonization and pulmonary infection in a murine model \[[@ppat.1008639.ref047]\]. Together, our work suggests the *in vivo* relevance of the role of the O antigen of leptospiral LPS for TLR4 signaling and confirms its importance to escape part of the innate immune responses, potentially favoring kidney colonization in mice. Among the numerous factors that could contribute to the attenuation of the leptospiral mutant, one could hypothesize that the stronger binding of the mutant LPS to CD14 and subsequent enhanced signaling could benefit the infected host in the fight against the pathogen. In the case of the M895 mutant, we have shown that it induces more NO than the WT strain, and we hypothesize that the activation of the TLR4-TRIF pathway could, in addition to the activation of TLR2, contribute to a strong innate immune recognition by the infected host, leading to better clearance and no kidney colonization in mice ([Fig 7](#ppat.1008639.g007){ref-type="fig"}). Our results thus provide for the first time a plausible explanation for the basis of attenuation of the LPS mutant M895. Accordingly, it was recently shown that *L*. *interrogans* serovar Autumnalis strain 56606v, which possesses an LPS atypically devoid of TLR2 activity and signaling only through TLR4 \[[@ppat.1008639.ref064]\], leads to a self-resolving leptospirosis and does not induce kidney colonization in mice. To our knowledge, besides the Patoc LPS described here, this is the first evidence of a leptospiral LPS naturally devoid of TLR2 activity. Upon infection with that specific leptospiral strain, TLR4 was shown to be essential to the resolution of the infection, and authors described a TLR4-dependent iNOS activation that they hypothesize could contribute to the leptospiral clearance in mice \[[@ppat.1008639.ref064]\]. Similarly, we show that LPS of *L*. *biflexa* Patoc, that is also devoid of TLR2 activity, induces TLR4-TRIF responses and we hypothesize that such mechanism contributes to the rapid clearance of the saprophytic bacteria by infected hosts \[[@ppat.1008639.ref005]\]. Conversely, these findings suggest that full length O antigen of the WT LPS and co-purifying lipoproteins contribute to the dampening of the TRIF signaling and potentially participate in the stealthiness of the pathogenic leptospires, leading to the productive infection and colonization of the kidneys in mice. Consistent, the lack of the gene encoding iNOS protein in mice has negligible effect on the outcome of infection by *L*. *interrogans* \[[@ppat.1008639.ref065],[@ppat.1008639.ref066]\]. Moreover, to our knowledge, only one study described a protective role of the TRIF adaptor upon induction of severe leptospirosis \[[@ppat.1008639.ref067]\] induced with 2 x 10^8^ leptospires per mouse. Such findings are consistent with our results showing that leptospires at high MOI, unlike LPS, can trigger NO in macrophages at 24h post infection although no mTLR4 internalization was visible at 1h post infection. This suggests that TRIF activation is impaired, but not entirely abolished, upon infection. Moreover, we cannot exclude the possibility that TRIF could be induced later, or by TLR2 activation \[[@ppat.1008639.ref068]--[@ppat.1008639.ref073]\] by lipoproteins upon infection, as illustrated by the *Leptospira*-induced production of NO in C3H/HeJ TLR4-defective mice \[[@ppat.1008639.ref073]\]. Overall, these studies suggest that TRIF plays a moderate role in the outcome of the infection by WT bacteria, unlike MyD88 \[[@ppat.1008639.ref074]\], and could be key to determine the outcome of both the acute phase and chronic kidney colonization in mice. Clinical studies have consistently reported that the escape of the TRIF-dependent RANTES production was important in clinical leptospirosis \[[@ppat.1008639.ref075]\]. Furthermore, it was also reported that anti-leptospiral IgM levels were slightly reduced in Trif*Lps2* mice \[[@ppat.1008639.ref067]\]. The low TRIF activation that we described here could therefore have impacts beyond the first line of innate immune defense and could also potentially dampen the humoral responses against *L*. *interrogans*.

To conclude, the recognition by mTLR4 is essential for host resistance against leptospirosis. Although leptospiral LPS is recognized by the mTLR4, we described here that *in vitro* it escapes the TRIF arm of the TLR4 response, hence dodging antimicrobial responses. Accordingly, another study \[[@ppat.1008639.ref064]\] has demonstrated that such mechanism is relevant *in vivo*. The novelty of the present work resides in the study of the signaling properties of the leptospiral LPS in its "crude" form, and investigation of the role played by the physiologically relevant copurifying lipoproteins. We propose that this partial innate immune escape of the leptospiral LPS in mice could be key to the stealthiness of the bacteria and to the chronicity of leptospires in resistant mice.

Materials and methods {#sec010}
=====================

*Leptospira* strains and cultures {#sec011}
---------------------------------

*L*. *interrogans* serovar Icterohaemorrhagie strain Verdun; serovar Manilae strain L495, strain M895 (shorter LPS \[[@ppat.1008639.ref007]\]) and strain M933 (ΔLipL32 \[[@ppat.1008639.ref076]\]); serovar Copenhageni strain Fiocruz L1-130, and *L*. *biflexa*: serovac Patoc strain Patoc were used in this study, and grown in liquid Ellinghausen-McCullough-Johnson-Harris medium (EMJH) at 30°C without antibiotics and agitation. All strains were subcultured weekly at 5 x 10^6^ leptospires/mL (or twice a week in the case of *L*. *biflexa*) and hence kept in exponential phase of growth.

Leptospiral LPS purification and quantification {#sec012}
-----------------------------------------------

LPS was extracted by the classical hot phenol/water protocol adapted from Westphal and collaborators \[[@ppat.1008639.ref035]\] and described recently \[[@ppat.1008639.ref077]\]. Silver staining analyses were performed as described by Tsai and Frasch \[[@ppat.1008639.ref078]\] and reviewed recently \[[@ppat.1008639.ref077]\]. LPS preparations were quantified by EndoQuant technology (Dijon, France) (direct assay to quantify the 3-hydroxylated fatty acids linked to the disaccharide of the lipid A). Lipoprotein contamination was assessed by SDS-PAGE and Western Blot (WB). Nitrocellulose membranes (BioRad) were blocked with 5% w/V BSA in Tris-Buffer-Saline-Tween (TBS-T) for 1 h at room temperature (RT), before staining over night at 4°C with 1:10 000 anti-LipL21 or anti-LipL32 polyclonal rabbit antiserum (kindly provided by Dr D. Haake) described previously \[[@ppat.1008639.ref079]\]. Membranes were washed 3 times with TBS-T and stained with 1:10 000 HRP-coupled anti-rabbit (anti-Rabbit IgG, HRP linked antibody from donkey, GE HealthCare) in blocking buffer for 1 h at RT. Development was performed after 3 washes in TBS-T and using Clarity ECL reagents (BioRad) and automatic exposure set up on ChemiDoc imaging system (BioRad).

Additional purification of LPS {#sec013}
------------------------------

LPS was further purified to remove the TLR2 activating co-purifying molecules. LPS was re-extracted by the isobutyric acid/1M ammonium hydroxide method \[[@ppat.1008639.ref080]\] and further purified by enzymatic treatment to remove DNA, RNA and proteins, then extracted with a mixture of solvents to remove phospholipids and lipoproteins as described \[[@ppat.1008639.ref081]\]. LPS preparations were also treated with proteinase K (from *Tritirachium album*, Qiagen) or lipase (from *Burkholderia* ssp., Sigma, active on triacylated lipoproteins) at final concentrations varying from 1 X to 4 X the amount of LPS. All treatments were performed at 37°C for 3 h.

LPS and CD14 binding assays {#sec014}
---------------------------

LPS-CD14 binding assays were performed by incubating 100 ng/mL of recombinant bovine sCD14-His \[[@ppat.1008639.ref082]\] with various concentrations of leptospiral LPS in PBS for 1 h at 37°C and under slow agitation at 300 rpm. Samples were then loaded on polyacrylamide native gels (stacking 4.5%, running 20%), ran in TG native buffer (BioRad) at constant voltage of 50 V for 6-8 h on ice and used for WB or silver staining. Silver staining was performed using the Pierce coloration kit (ThermoFisher) according to the manufacturer's instructions. Images were acquired within 30 min of development. WBs were performed after turbo transfer to nitrocellulose membrane (BioRad) and blocking in 5% w/V BSA in PBS-Tween (PBS-T). Membrane was then stained with 1 μg/mL of HRP coupled anti-His (monoclonal mouse anti-polyHistidine-Peroxidase, Sigma-Aldrich) in 1% w/V BSA in PBS-T over night at 4°C. Signal was visualized after three washes and with Clarity ECL reagents (BioRad) using automatic exposure on ChemiDoc imaging system (BioRad).

Human embryonic kidney cells reporter system {#sec015}
--------------------------------------------

Human embryonic kidney cells (HEK293T) cells were cultured in complete DMEM composed of DMEM GlutaMAX (Gibco), supplemented with 10% V/V heat inactivated Fetal Calf Serum (Hi FCS, Gibco), 1 mM sodium pyruvate (Gibco) and 1 X non-essential amino acids (Gibco). Transfections were performed in 24-well plates (TPP) at 60% confluence with a final amount of 300 ng of DNA per well (50 ng of NF-κB reporter luciferase; 25 ng of internal control β-galactosidase; 50 ng of hTLR2; completed with empty pcDNA3.1 vector) and using FuGENE HD 1x (Promega) in serum-free conditions following the supplier's indications. Briefly, DNA and transfection reagents were incubated for 25 min at RT before addition to the cells. The cells used for TLR4 activity were stably transfected with mTLR4, mCD14 and mMD2 (Invivogen). Cells were stimulated 24 h post transfection for 6 h with LPS, and controls for TLR4 or TLR2 activity, namely LPS from *E*. *coli* O111:B4 UltraPure (Invivogen) or Pam3Cys (Invivogen) respectively. Cells were lysed in 100 μL of lysis buffer (25 mM Tris pH 8; 8 mM MgCl~2~; 1% V/V triton X-100; 15% V/V glycerol; 1 mM DTT). 10 μL were used for β-galactosidase assay by addition of 100 μL of substrate (1 mg/mL ONPG in 0,06 M Na~2~HPO~4~; 0,04 M NaH~2~PO~4~; 0,01 M KCl; 0,001 M MgSO~4~; 1 mM DTT), incubation at 37°C for 20 min, followed by absorbance measurement at 450 nM on Elx808 analyzer (BioTek).10 μL were used for NF-κB reporter luciferase assay by addition of 100 μL of 1 mM luciferin and 0.1 M ATP in lysis buffer and analysis on Berthold Centro X100 luminometer. Luciferase reporter assay values were individually normalized by β-galactosidase and reported as NF-κB activation.

Macrophages culture and stimulation {#sec016}
-----------------------------------

Bone marrow derived macrophages (BMDMs) were obtained after euthanasia by cervical dislocation of C57BL/6 adult mice (more than 6 weeks-old female or male): WT (Janvier, Le Genest, France), and Trif*Lps2*, MyD88 KO, TLR2 KO, TLR4 KO, all bred by the Institut Pasteur animal facility and described previously \[[@ppat.1008639.ref065]\]. After isolation of the femurs, head of the bones were cut, and the bone marrow was flushed out with a 22 G needle. Cells were centrifuged at 300 g for 7 min and erythrocytes were lysed for 10 min with Red Blood Cells Lysis Buffer (Sigma-Aldrich). After a second centrifugation, the bone marrow cells were counted with Trypan blue (Gibco) and plated in culture dishes (TPP) with 5 x 10^6^ cells/dish in 12 mL of complete RPMI (RPMIc): RPMI (Gibco) with 10% V/V Hi FCS (Gibco), 1 mM sodium pyruvate (Gibco) and 1 X non-essential amino acids (Gibco). RPMIc was supplemented with 1 X antibiotic-antimycotic (Gibco) and 10% V/V L929 cells supernatant to differentiate them to macrophages (obtained from confluent cultures and filtered through 0,22 μm). Cells were incubated at 37°C, 5% CO~2~ for 7 days (with addition of 3 mL of differentiation medium at day 3). BMDMs were recovered at day 7 by scraping in Cell Dissociation Buffer (Gibco) and centrifugation at 300 g for 7 minutes. BMDMs were plated 3 h before stimulation at a concentration of 1 x 10^6^ cells/mL in 96-well plates (TPP) with 200 μL per well.

RAW264.7 (macrophage-like cell line) cells were plated the night before stimulation at a concentration of 0,5 x 10^6^ cells/mL in 96-well plates with 200 μL per well in RPMIc. For the experiments performed without FCS and with sCD14, FCS was progressively removed and the recombinant soluble bovine CD14-His \[[@ppat.1008639.ref082]\] was added before stimulation. RAW264.7 cells or BMDM were stimulated for 24 h with leptospiral LPS, whole bacteria or other agonists: LPS of *E*. *coli* O111:B4 (UltraPure or EB, Invivogen), Poly(I:C) HMW (Invivogen), Pam3Cys (Invivogen).

ELISA and Griess reaction {#sec017}
-------------------------

For mouse-KC/CXCL1 and mouse-RANTES/CCL5 quantification, ELISA was performed on cell culture supernatants that were kept at -20°C. ELISA DuoSet kits (R&D Systems) were used according to the manufacturer's instructions. The nitric oxide (NO) was quantified in the fresh supernatant by the Griess reaction.

RT-qPCR {#sec018}
-------

Frozen mouse cells were used for RNA extractions that were performed using RNeasy Mini kit (Qiagen) and according to the supplier's instructions. Reverse transcription was performed immediately after extraction and using SuperScript II Reverse Transcriptase (Invitrogen) according to manufacturer's instructions. cDNA obtained was quantified using NanoDrop (Thermo Fisher Scientific), frozen and kept at -20°C for qPCR. Five μg of cDNA were used for RT-qPCR using Taqman Universal Master Mix II (Applied Biosystems). Primers and probes are listed in [S1 Table](#ppat.1008639.s001){ref-type="supplementary-material"}. RT-qPCR was performed on a StepOnePlus Real Time PCR System (Applied Biosystems) with the standard protocol (2 h) and fold change was calculated with the 2^-ΔΔCτ^ method on the average of the technical duplicates.

Immunofluorescence staining, confocal microscopy and image quantification {#sec019}
-------------------------------------------------------------------------

Cells were seeded at 0,2 x 10^6^ cells/mL in 24-well plates containing 12 mm round coverslips (\#1.5 mm thickness, Electron Microscopy Science) with 1 mL per well and stimulated as described above. Cells were fixed 1 h post stimulation with 3% V/V *para*-formaldehyde for 10 min and washed 3 times with PBS. Cells were stained as follows: 1- blocking with 2 μg/mL FcBlock (anti mouse CD16/CD32, Invitrogen) for 1 h at RT in microscopy buffer (5% w/V BSA (Sigma), 0,06% w/V saponin (Sigma) in PBS); 2- incubation with 0.5 μg/mL primary anti mouse-TLR4 (recombinant monoclonal rabbit IgG, clone \#1203B, R&D Systems) in microscopy buffer for 1 h at RT; 3- three washes with wash buffer (1% w/V BSA in PBS); 4- incubation with 4 μg/mL secondary goat anti rabbit conjugated with AlexaFluor(AF)488 (goat IgG H+L, Invitrogen) in microscopy buffer for 1 h at RT; 5- three washes in wash buffer; 6- incubation with 1 μg/mL DAPI(Invitrogen) staining nuclei and 2 μg/mL Wheat Germ Agglutinin (Invitrogen) conjugated with AF594 staining all glycoproteins in permeabilized cells in 5% w/V BSA in PBS for 10 min at RT; 7- three washes with PBS. Coverslips were mounted with Fluoromont (Sigma) and kept at RT over night before imaging. All images were obtained with a Leica SP5 confocal microscope using a 63x, 1.4 N.A., oil immersion objective. The following parameters were used: pinhole size of 1 Airy Unit (default setting), scanning frequency of 200 Hz, line average of 4. UV laser was used for DAPI, Argon for AF488 and 594HeNe for AF594, with power between 5 to 15%. Sequential acquisition by channel was performed using a hybrid detector for AF488 (gain range from 70% to 100%) and photomultipliers for AF594 and DAPI (voltage between 700 to 900 V). Raw images were analyzed with ImageJ-Fiji \[[@ppat.1008639.ref083]\]. Contrast and brightness were homogeneously enhanced (10%) on the representative images shown for each experiment. mTLR4 fluorescence profiles were obtained by measuring the AF488 intensity along a straight cross-section drawn manually across the cell and according to the following criteria ([S1B Fig](#ppat.1008639.s002){ref-type="supplementary-material"}): direction = perpendicular to the length of the macrophages, localization = next to the nucleus, width = 30 pixels. Results obtained for 30 to 60 cells were averaged and plotted as a function of the position across the cell.

Flow cytometry {#sec020}
--------------

Cells were seeded at 0,5 x 10^6^ cells/mL in 24-well plates with 1mL per well and stimulated as described above. Macrophages were detached with 10 mM EDTA in PBS for 15 min and were transferred to round bottom 96-well plates, centrifuged at 1000 g for 7 min and then incubated for 35 min on ice in 50 μL of 2 μg/mL FcBlock (anti mouse CD16/CD32) in cytometry buffer (PBS, 0,5% V/V FCS, 2 mM EDTA). Cells were stained with 25 μL of 0.5 μg/mL primary anti mouse-TLR4 (recombinant monoclonal rabbit IgG, clone \#1203B, R&D Systems) or isotype (normal polyclonal rabbit IgG control, R&D Systems) in cytometry buffer for 45 min on ice. Cells were then washed by addition of 100 μL of cytometry buffer and centrifuged. The supernatants were discarded before staining with 50 μL of 2 μg/mL secondary AF488 goat anti rabbit (goat IgG H+L, Invivogen) in cytometry buffer for 30 min on ice. 25 μL of fixable viability dye efluor780 (eBioscience) was added for 5 min on ice. Cells were fixed by addition of 50 μL of 2% V/V *para-*formaldehyde for 10 min on ice, washed by addition of 100 μL of cytometry buffer and centrifuged before resuspension in buffer and storage at 4°C for a maximum period of 24 h before acquisition. Acquisition was done on CytoFLEX (Beckman Coulter) after calibration; 10.000 to 30.000 events were recorded for each condition. Analysis was performed using the FlowJo V10 software. The mean fluorescence intensity (MFI) for mTLR4 corresponds to live cells.

Statistical analyses {#sec021}
--------------------

All the statistical analyses were performed using non-parametric Mann-Whitney test: \* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001. Unless otherwise specified, all experiments were performed with technical triplicates and are representative of at least three independent experiments.

Ethics statement {#sec022}
----------------

All the experiments involving mice conformed with the European Union directive (2010/63 EU) and the French regulation for protection of laboratory animals (February 1, 2013). Project (HA-0036) was approved by the Institut Pasteur ethics committee (CETEA\#89).

Supporting information {#sec023}
======================

###### List of primers for RT-qPCR experiments.

(DOCX)

###### 

Click here for additional data file.

###### Leptospiral LPS does not trigger TLR4 internalization.

(TIF)

###### 

Click here for additional data file.

###### Leptospiral LPS avoids TRIF-dependent responses but activates MyD88.

(TIF)

###### 

Click here for additional data file.

###### Shorter leptospiral LPS induces more TLR4-TRIF responses.

(TIF)

###### 

Click here for additional data file.

###### Soluble CD14 participates in the enhanced signaling of the shorter leptospiral LPS.

(TIF)

###### 

Click here for additional data file.

###### Copurifying lipoproteins contribute to the escape of TLR4 internalization.

(TIF)

###### 

Click here for additional data file.
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Dear Dr. Werts,

Thank you very much for submitting your manuscript \"Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins\" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. In addition, for those not familiar with Leptospira  and leptospirosis, I believe that it would be helpful to add a sentence or two to the discussion to proide biological context to your findings, e.g. how this work might affect which host animals are susceptible to severe disease vs. mild disease or asymptomatic carriage.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. 

When you are ready to resubmit, please upload the following:

\[1\] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

\[2\] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Sincerely,

Jenifer Coburn, PhD
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Renée Tsolis
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Reviewer Comments (if any, and for reference):

Reviewer\'s Responses to Questions

**Part I - Summary**

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer \#1: The host response to bacterial lipopolysaccharide (LPS) is mediated via signaling through the pattern-recognition receptor Toll-like receptor 4 (TLR4) via two pathways: a MyD88-dependent route upon recognition of the antigen by TLR4 at the cell surface, and a TRIF-dependent route upon subsequent internalization of LPS-bound TLR4. The authors describe previous work characterizing the unique manner in which the LPS of Leptospira interrogans interacts with the host response, including that although this LPS signals through murine TLR4, it is less endotoxic than the LPS of certain other microbes. In addition, certain lipoproteins that co-purify with leptospiral LPS have been shown to aid in evasion of the early host response. In this report, the authors provide a methodical and thorough investigation of these aspects of the TLR4-mediated host response to LPS of L. interrogans.

Here, the authors show that, unlike the LPS of Escherichia coli, the LPS of a pathological L. interrogans strain did not induce internalization of TLR4. This lack of TLR4 internalization was also observed using the LPS of other L. interrogans serovars, different concentrations of LPS, and different durations of incubation with host cells. High concentrations of leptospiral LPS were shown to less effectively stimulate TRIF-dependent (TLR4-internalized) pathways than LPS of E. coli, leading to less production of nitric oxide (NO) and RANTES, while still stimulating MyD88-dependent pathways. The authors then showed that strains with shorter LPS allowed for more effective internalization of TLR4 and greater production of NO and RANTES than did pathogenic strains with full-length LPS, leading to the hypothesis that possession of full-length LPS allowed for the evasion of TLR4 internalization and the ensuing activation of TRIF-dependent responses. Soluble CD14, a key component of TLR4 signaling, was shown to significantly aid in the production of a TRIF-dependent product in response to the shorter LPS but not to the full-length LPS; the authors hypothesized, after performing binding assays, that the latter effect could be due to a lower affinity between full-length LPS and sCD14. Additionally, leptospiral LPS that was re-purified, with the effect of significantly removing associated lipoproteins, led to increased internalization of TLR4 and increased transcription/production of various TRIF-dependent immune factors. Digestion of LPS with proteinase K led to increased RANTES production, indicating that the protein components of lipoproteins associated with LPS aid in the escape from TRIF signaling. Finally, the findings were supported with a study using whole L. interrograns microbes.

Collectively, these novel findings describe important mechanisms by which L. interrograns can effectively evade critical factors of the host response. The authors' findings were supported using various experimental methods and were bolstered by robust primary and supplementary data. This was an exceptionally well written and logical manuscript that is suitable for publication with some minor modifications.

Reviewer \#2: This is a well-conceived paper by a group of experienced investigators that have a long track record studying the biochemical characteristics of Leptospiral LPS and the host immune response to Lepto LPS in mouse and human cells. They hypothesize that Leptospira LPS, known as a virulence factor, plays a major role in the innate immune evasion of the leptospires, thereby contributing to their stealthy-ness and chronicity in mice. It is a very important study as they provide novel mechanistic data showing that Leptospira LPS escapes the TRIF arm of the TLR4 response to evade RANTES and NO antimicrobial responses. The paper is generally well written and the figures, captions and legends help the reader quickly follow the main objective of the study. One weakness throughout is the lack of clarity between distinction of assessments between mouse and human TLR4. Another is lack of consistency in defining what leads to immune evasion that leads to tolerance and resistance (decreased susceptibility) to infection and evasion from one pro-inflammatory pathway (but not the other) that would lead to increased susceptibility to infection.

Reviewer \#3: The manuscript by Bonhomme and colleagues examines cell signaling downstream of the binding of leptospiral LPS to Toll-like receptors with the aim to understand its low endotoxicity. The authors show that leptospiral LPS does not trigger internalization of TLR4, which is potentially linked to its reduced ability to trigger TRIF-dependent responses while MyD88-dependent responses remain intact. Moreover, the group shows that contaminating lipoproteins contribute to the TLR2 response of the LPS but also appear to impair TLR4 internalization and TRIF-dependent responses.

Overall, these are nice findings but there are a few issues to address.

\*\*\*\*\*\*\*\*\*\*

**Part II -- Major Issues: Key Experiments Required for Acceptance**

Please use this section to detail the key new experiments or modifications of existing experiments that should be [absolutely]{.ul} required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a \"Major Revision\" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend \"Reject\".

Reviewer \#1: 1. At the risk of adding to the abundant data presented here, it was noted that the TRIF-dependent products examined were not presented or described regularly throughout the main figures. It appears that levels of NO were consistently shown, but data on RANTES and, moreso, IL-1beta were not. And, no data on production of IL-1beta protein were shown. A lack of this information does not necessarily negate the main conclusions of this study, but it seems that inclusion of such additional data would further strengthen their conclusions. Would the authors please comment on why these products were not more consistently shown?

2\. In Figure 6, the effect of the shorter M895 on NO production was shown, but what about the effect of this microbe on internalization of TLR4?

Reviewer \#2: Since there are comparisons between human and mouse TLR4 and TLR2 the authors need to clearly identify throughout the paper what is mouse and what is human. For example, the Abstract and Summary both start with emphasis on human and then end up explaining data seen in mouse. In Discussion it is also important to lead in the first paragraph with the clarification that the data discussed is mouse data (and comparisons and differences w human need to be highlighted throughout).

Reviewer \#3: Figure 1: The intensity of the IF stain needs to be increased; it was difficult to see in my copy. Also, please indicated what WGA is staining? While KC induction is fully dependent on MyD88, it's not clear how much of that signal is TLR4 vs TLR2 dependent. In Figure S2A, the stats are not included for the KC values in the TLR2 and TLR4KO. Did the authors test TLR2/4 double KOs to ensure all of the signal is going through these receptors? Ensure to provide stat tests for mRNA levels in 1B.

The authors also show at low concentrations, leptospiral LPS does not activate either pathway -- how does this concentration of LPS relate to an infectious dose? Also, would it be informative to see in vivo with leptospiral LPS injection in mice that it does not induce TRIF-dependent responses? This might hint at importance during in vivo infection.

Figure 3C -- Again here the IF was not very easy to see. Also, should include an E coli LPS to compare with the M895 strain.

Figure 3D -- Would also be helpful to have comparison with KC; also mRNA levels would add to data.

Figure 4: Western blot for CD14 needs to be improved.

Figure 5D: Again the signal here is difficult to see. G) Stats required.

Figure 6A: For the IF, would be good to have L495 as a comparison.

\*\*\*\*\*\*\*\*\*\*

**Part III -- Minor Issues: Editorial and Data Presentation Modifications**

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer \#1: 1. Line 141: Figure 1SA doesn't seem show the data described in this sentence, which describes stimulated cells.

2\. Line 147: "cells" needed after RAW264.7.

3\. Line 173: Were these cells RAW264.7 cells? The caption for Figure 2B states BMDMs.

4\. Line 205: What is meant by "comparable activity" here? The values are different, although the comparison to NS conditions is the same.

5\. Line 284: Perhaps "from", instead of "to".

6\. Line 417: Perhaps "another", instead of "other".

7\. Line 505: Perhaps "macrophage", instead of "macrophages".

8\. Lines 835, 837, 893, 907: It is unclear what is meant by "panel" here.

9\. Line 839: Missing an open parenthesis.

10\. Line 877: "Blot", rather than "Bot".

11\. Line 963: L495 LPS isn't mentioned here.

12\. Lines 970-974: The description of the dark/light green bars was somewhat confusing. Should the lipase bars in Figures S5B and S5D be light green?

13\. Figure S5G: Should "M933" be included in the data label for the LipL32 mutant, as stated in Line 981?

14\. Lines 983-984: Wording of "green bars" (plural) to describe each individual group was somewhat confusing.

Reviewer \#2: Minor:

Abstract

Line 30-31: needs clarification.

Introduction

In general, this section is very long. Some of this information may be better used in discussion to explain the results observed?

Line 61: I think a more accurate term in this context is enzootic (rather than zoonotic)

Line 72 and 109: consider unconventional instead of peculiar

Line 91: delete interferons (because IFN is a cytokine)

Line 105: consider deleting stricto sensu because it translates into essential

Line 122: consider replacing mystery with unknown

Results

Line 135: after membrane TLR4 add (mTLR4?), it needs to be clarified if mTLR4 stands for membrane or mouse? given that in Fig S3B mTLR4 stands for mouse.

Line 163 (Fig 2): why only 24h? was the analysis not done at 1h also?

Lines 186-188: this setup is a bit confusing, it needs clarification.

Fig 3B: adding the E.coli control here helps visualize the differences

Fig 3C: There not much difference between NS L495 and M895 mTLR4 staining in this figure. This may be easier to visualize against the Ecoli control.

Line 204-206: This comparison needs to be done on the same graph with the same axis. It looks like mTLR4 in LPS Patoc is 5-6X lower than LPS Verdun and hTLR2 is 8X lower?

Line 246: add Fig 5c after treatment (for the silver stain fig)

Fig 5D and 5E: it helps to visualize this against the E. coli control. This is mouse and human. It needs to be clarified

Line 254: replace more produced with increased

Fig 6B: it helps to visualize this against the E. coli control

Line 284: consider replacing participates with contributes

Discussion:

The authors need to better differentiate the use of the term "escape immunity" that lead to tolerance or resistance in mouse from "escape" that leads to susceptibility and severe disease, this becomes quite confusing to the reader. Maybe use escape immunity + stealth of the pathogen, but not escape+virulence of the pathogen.

Discuss the Patoc data.

Line 415: Clarify that this is mouse in the beginning of the sentence.

Methods

HEK293T: clarify that these are human cells.

Where's your mouse RAW264 macrophages?

Reviewer \#3: see above

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plospathogens/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

[Figure Files:]{.ul}

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, [[https://pacev2.apexcovantage.com](https://pacev2.apexcovantage.com/)]{.ul}. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at [<figures@plos.org>]{.ul}.

[Data Requirements:]{.ul}

Please note that, as a condition of publication, PLOS\' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: <http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5>.

[Reproducibility:]{.ul}

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see [[http://journals.plos.org/plospathogens/s/submission-guidelines\#loc-materials-and-methods](http://journals.plos.org/plospathogens/s/submission-guidelines)]{.ul}
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Click here for additional data file.
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Dear Dr. Werts,

We are pleased to inform you that your manuscript \'Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins\' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Jenifer Coburn, PhD
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Dear Dr. Werts,

We are delighted to inform you that your manuscript, \"Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins,\" has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc\...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief
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Michael Malim

Editor-in-Chief
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